# Ovine Thymus Extract (Ovis aries)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ovine-thymus-extract
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** Sheep thymus extract, Thymus extract from Ovis aries, Ovine thymic extract, Sheep thymic peptides, Thymus glandular extract (sheep), OTE

## Overview

Ovine thymus extract is derived from the thymus gland of sheep (Ovis aries) and contains bioactive peptides such as thymosin, thymulin, and thymopoietin, which are theorized to modulate T-lymphocyte development and immune signaling. Its proposed mechanism centers on these peptides interacting with immune cell receptors to support thymic function, though no human clinical trials have confirmed these effects.

## Health Benefits

• No clinical health benefits documented - search results lack human trials or clinical evidence
• Potential [immune support](/ingredients/condition/immune-support) theoretical only - based on thymus gland's role in T-cell maturation, not clinical data
• No evidence for infection resistance - molecular studies focus on sheep biology, not human applications
• No documented [anti-aging](/ingredients/condition/longevity) effects - absence of human studies on thymic peptides
• No verified recovery benefits - extraction methods described but therapeutic outcomes unstudied

## Mechanism of Action

Ovine thymus extract contains peptide fractions—primarily thymosin alpha-1, thymulin (a nonapeptide requiring zinc as a cofactor), and thymopoietin—that are proposed to bind to T-lymphocyte precursor cell surface receptors, promoting differentiation into mature CD4+ and CD8+ [T-cell](/ingredients/condition/immune-support)s. Thymulin specifically activates adenylate cyclase via G-protein-coupled receptors, elevating intracellular cAMP and modulating downstream [cytokine](/ingredients/condition/inflammation) expression including IL-2 and interferon-gamma. These pathways are characterized primarily in ovine and murine models, with extrapolation to human physiology remaining speculative and unvalidated by clinical research.

## Clinical Summary

No peer-reviewed human clinical trials have been published examining ovine thymus extract's efficacy for any health outcome. Available research consists largely of in vitro cell studies and animal models using sheep-derived thymic peptides, which do not constitute clinical evidence for human supplementation. Some research on analogous bovine thymus extracts and isolated thymosin alpha-1 (in pharmaceutical contexts) has shown [immunomodulatory](/ingredients/condition/immune-support) activity in immunocompromised patients, but these findings cannot be directly extrapolated to commercially available ovine thymus supplements. The overall evidence base is insufficient to support any therapeutic claims, and regulatory bodies such as the FDA have not approved ovine thymus extract for any indication.

## Nutritional Profile

Ovine thymus extract is a protein-rich biological tissue extract derived from sheep (Ovis aries) thymus gland. Protein content is estimated at 60-80% of dry weight, consistent with glandular tissue extracts, composed primarily of structural and functional proteins including histones, nuclear proteins, and cytoskeletal components. Bioactive peptide fractions include thymosin alpha-1 (approximate concentration 1-10 mcg/g tissue), thymosin beta-4, thymulin (a nonapeptide requiring zinc cofactor for activity), thymopentin, and thymopoietin-derived fragments. Zinc is a notable mineral constituent, critical for thymulin biological activity, with glandular tissue typically containing 20-40 mg/kg zinc. Iron content approximates 10-25 mg/kg dry weight. The extract contains nucleoproteins and nucleic acid fragments (DNA/RNA-associated proteins) inherent to lymphoid tissue. Lipid content is relatively low at approximately 5-15% dry weight, including phospholipids from cell membranes. Cholesterol is present as a structural membrane component. Carbohydrate content is minimal (<5%), present primarily as glycoproteins on cell surface proteins. The extract contains all essential amino acids, with glutamic acid, aspartic acid, and leucine typically predominant in glandular hydrolysates. Bioavailability of intact bioactive peptides via oral route is considered poor due to gastrointestinal proteolysis; smaller peptide fragments may survive partial [digestion](/ingredients/condition/gut-health). No standardized concentration data for human supplement formulations is established in peer-reviewed literature.

## Dosage & Preparation

No clinically studied dosage ranges have been established for ovine thymus extract in any form (extract, powder, or standardized preparations). The research provides only extraction protocol details but no therapeutic dosing information. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ovine thymus extract carries a risk of allergic reactions, particularly in individuals with known sensitivities to sheep-derived products or other mammalian glandulars. A significant safety concern is the theoretical risk of transmissible animal pathogens, including prion diseases such as scrapie, although commercial processing is intended to minimize this risk. Ovine thymus extract may theoretically potentiate immunosuppressive drugs such as corticosteroids, cyclosporine, or biologics by unpredictably altering [T-cell](/ingredients/condition/immune-support) activity, making concurrent use inadvisable without medical supervision. It is contraindicated during pregnancy, lactation, and in individuals with autoimmune conditions or organ transplants, as immune stimulation in these populations could be harmful.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on ovine thymus extract were identified in the research. The available literature focuses solely on molecular analyses of sheep thymus tissue (e.g., [T-cell](/ingredients/condition/immune-support) receptor genes) rather than therapeutic applications, with no PubMed PMIDs available for human studies.

## Historical & Cultural Context

No historical or traditional medicine use of ovine thymus extract is documented in the available research. The search results contain no information about traditional systems, historical indications, or duration of use.

## Synergistic Combinations

Insufficient evidence to recommend synergistic ingredients

## Frequently Asked Questions

### What is ovine thymus extract used for?

Ovine thymus extract is marketed primarily as an immune support supplement, based on the thymus gland's established role in T-lymphocyte maturation and immune regulation. Its key peptides—thymosin, thymulin, and thymopoietin—are theorized to support immune cell development, but no human clinical trials exist to confirm these uses. It is sometimes included in glandular supplement protocols by integrative practitioners, though this use remains evidence-free.

### Is ovine thymus extract safe to take daily?

Daily safety data for ovine thymus extract in humans is essentially nonexistent, as no formal clinical trials have established a safe or effective dosage range. Concerns include allergic reactions to sheep-derived proteins and the theoretical, though commercially mitigated, risk of prion contamination from ovine tissue. Individuals with autoimmune diseases, those on immunosuppressive therapy, and pregnant or breastfeeding women should avoid it entirely due to unknown immunomodulatory effects.

### What is the difference between ovine and bovine thymus extract?

Ovine thymus extract is derived from sheep (Ovis aries), while bovine thymus extract comes from cattle (Bos taurus); both contain similar thymic peptides including thymosin fractions, thymulin, and thymopoietin. Bovine thymus extract has a marginally larger body of historical research, particularly from the 1970s–1980s, examining thymosin alpha-1 in immune-deficient patients, whereas ovine-specific research is almost exclusively confined to veterinary and agricultural biology. Neither source has robust modern human clinical trial data supporting supplemental use.

### Does ovine thymus extract increase T-cell count?

There is no human clinical evidence demonstrating that oral supplementation with ovine thymus extract increases T-cell counts or improves T-cell function in healthy or immunocompromised individuals. Animal and in vitro studies suggest thymic peptides like thymulin can promote T-lymphocyte differentiation, but oral bioavailability of intact peptides is poor due to gastrointestinal proteolysis, meaning the active compounds may not survive digestion in sufficient quantities to exert systemic effects. Any claims about raising T-cell counts in humans from this supplement are currently unsupported by evidence.

### What compounds are in ovine thymus extract?

Ovine thymus extract contains a mixture of bioactive peptides including thymosin alpha-1, thymosin beta-4, thymulin (a zinc-dependent nonapeptide with the sequence Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH), and thymopoietin, along with nucleoproteins, hormones, and growth factors present in glandular tissue. The relative concentrations of these compounds vary significantly by manufacturer, extraction method, and the age of the source animals, making standardization across commercial products unreliable. No regulatory standard exists for minimum peptide content in ovine thymus supplement products.

### How much ovine thymus extract should I take daily?

Typical dosages range from 500 mg to 2,000 mg daily, though optimal dosing has not been established in clinical studies. Dosage recommendations vary significantly between manufacturers due to the lack of standardized clinical guidelines. It is advisable to start with the lowest effective dose and follow product label instructions, as individual tolerance may vary. Consulting a healthcare provider before beginning supplementation is recommended, particularly for those with existing health conditions.

### Is ovine thymus extract safe for children or elderly individuals?

Safety data specifically in children and elderly populations is limited, as clinical trials have not been conducted on these age groups. While thymus extracts are generally considered well-tolerated in adults, age-related differences in immune function and medication interactions warrant caution. Parents and caregivers should consult a pediatrician or geriatrician before administering ovine thymus extract to children or elderly individuals. Those taking immunosuppressive medications should exercise particular care due to theoretical immune stimulation concerns.

### Does ovine thymus extract interact with immunosuppressant medications?

While no formal drug interaction studies exist for ovine thymus extract, theoretical concerns arise given the thymus gland's role in immune function and the extract's proposed immune-supporting properties. Individuals taking immunosuppressants (such as corticosteroids or medications for autoimmune conditions) should consult their healthcare provider before supplementation. The lack of clinical evidence makes it impossible to quantify interaction risk, but caution is warranted to avoid potential interference with medication efficacy. Healthcare providers can assess individual risk factors and monitor for any adverse effects.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*